申请人:Senju Pharmaceutical Co., Ltd.
公开号:EP1224945A1
公开(公告)日:2002-07-24
Use of a chymase inhibitor in preventing and treating nearsightedness caused by the continuous tension of ciliary muscles makes it possible to achieve exact preventive and therapeutic effects with little side effects.
使用糜蛋白酶抑制剂来预防和治疗因睫状肌持续紧张而引起的近视,可以达到确切的预防和治疗效果,而且副作用很小。